Cargando…

Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection

RSV infection is a leading cause of lower respiratory tract infection, especially in High-risk infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), neuromusculair impairment, immunodeficiency, and Down syndrome. Host related risk factors that have...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Constanze, Resch, Bernhard, Simões, Eric A.F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258650/
https://www.ncbi.nlm.nih.gov/pubmed/22262987
http://dx.doi.org/10.2174/1874285801105010144
_version_ 1782221287560577024
author Sommer, Constanze
Resch, Bernhard
Simões, Eric A.F
author_facet Sommer, Constanze
Resch, Bernhard
Simões, Eric A.F
author_sort Sommer, Constanze
collection PubMed
description RSV infection is a leading cause of lower respiratory tract infection, especially in High-risk infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), neuromusculair impairment, immunodeficiency, and Down syndrome. Host related risk factors that have been identified to be associated with severe RSV related lower respiratory tract infection include young age below 6 months at the beginning of RSV season, multiple birth, male sex, low socioeconomic status and parental education, crowded living conditions, young siblings, maternal smoking and indoor smoke pollution, malnutrition/small for gestational age, family history of atopy or asthma, low cord serum RSV antibody titers, and living at altitude. Risk factors increasing the risk of acquisition of RSV have been identified to be birth before and/or during RSV season, day care attendance, presence of older siblings in school or day-care, and lack of breast feeding. Some of these risk factors are discussed controversially and some of them are found continuously throughout the literature. Given the high cost of RSV prophylaxis, especially for the large population of late preterm infants, algorithms and risk score systems have been published that could identify high-risk infants for treatment with palivizumab out of this gestational age group. Several models reported on an average sensitivity and specificity of 70 percent and, thus, are helpful to identify infants at high risk for severe RSV infection and need for prophylaxis with palivizumab.
format Online
Article
Text
id pubmed-3258650
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-32586502012-01-19 Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection Sommer, Constanze Resch, Bernhard Simões, Eric A.F Open Microbiol J Article RSV infection is a leading cause of lower respiratory tract infection, especially in High-risk infants with a history of prematurity, bronchopulmonary dysplasia (BPD), congenital heart disease (CHD), neuromusculair impairment, immunodeficiency, and Down syndrome. Host related risk factors that have been identified to be associated with severe RSV related lower respiratory tract infection include young age below 6 months at the beginning of RSV season, multiple birth, male sex, low socioeconomic status and parental education, crowded living conditions, young siblings, maternal smoking and indoor smoke pollution, malnutrition/small for gestational age, family history of atopy or asthma, low cord serum RSV antibody titers, and living at altitude. Risk factors increasing the risk of acquisition of RSV have been identified to be birth before and/or during RSV season, day care attendance, presence of older siblings in school or day-care, and lack of breast feeding. Some of these risk factors are discussed controversially and some of them are found continuously throughout the literature. Given the high cost of RSV prophylaxis, especially for the large population of late preterm infants, algorithms and risk score systems have been published that could identify high-risk infants for treatment with palivizumab out of this gestational age group. Several models reported on an average sensitivity and specificity of 70 percent and, thus, are helpful to identify infants at high risk for severe RSV infection and need for prophylaxis with palivizumab. Bentham Open 2011-12-30 /pmc/articles/PMC3258650/ /pubmed/22262987 http://dx.doi.org/10.2174/1874285801105010144 Text en © Sommer et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Sommer, Constanze
Resch, Bernhard
Simões, Eric A.F
Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title_full Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title_fullStr Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title_full_unstemmed Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title_short Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
title_sort risk factors for severe respiratory syncytial virus lower respiratory tract infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258650/
https://www.ncbi.nlm.nih.gov/pubmed/22262987
http://dx.doi.org/10.2174/1874285801105010144
work_keys_str_mv AT sommerconstanze riskfactorsforsevererespiratorysyncytialviruslowerrespiratorytractinfection
AT reschbernhard riskfactorsforsevererespiratorysyncytialviruslowerrespiratorytractinfection
AT simoesericaf riskfactorsforsevererespiratorysyncytialviruslowerrespiratorytractinfection